Researchers have for the first time shown that standard tuberculosis (TB) diagnostic tests can be replaced by a sub-24 hour genetic test applied to the TB bacteria in a patient’s sputum. Dr Zamin Iqbal from the Wellcome Trust Centre of Human Genetics co-led this study.
LAB282, the £13m drug discovery partnership for Oxford University, has made its first wave of awards, backing projects targeting cardiovascular and infectious diseases including the 'Drugs from Bugs' project led by Prof. Shoumo Bhattacharya.
Professor Cecilia Lindgren has received the Khwarizmi International Award (KIA) for her work on "Dissection of the Molecular Pathogenesis of Obesity and Fat distribution". The Khwarizmi International Award seeks to recognize the efforts made by researchers, innovators and inventors from all over the world.
Specially invited speakers, among them some of the world's finest researchers, will speak about their latest achievements and research on colorectal cancer. The lectures are open to all interested in advances within research on colorectal cancer, and the theme for this meeting is Genomic stability and instability in cancer.
WTCHG Director, Prof Peter Donnelly, spoke as part of a Prof Brian Cox chaired panel for the Royal Society's event "Science Matters - Machine Learning and Artificial intelligence".
Wellcome has announced funding of £118 million to 14 major research centres, including three centres based in Oxford. The Wellcome Centre for Human Genetics, based in Oxford for 22 years, has played a pioneering role in the progress and success of human disease genetics and mechanism research.
We have now made available additional Oxford Nanopore sequencing data, adding raw data files to the existing dataset.
Scientists from the Wellcome Trust Centre for Human Genetics (WTCHG) have used Oxford Nanopore Technologies MinION sequencing devices to sequence two human DNA samples, in an exploration of the capabilities of the pocket-sized, USB-powered sequencing devices.
Dr Rose Wilson, of the Green lab, has written of their experience running a stall at the 'Science Uncovered' late-night event at the Natural History Museum, London.
Dr. Claire Palles, part of the Tomlinson group based at the WTCHG, has been highlighted by the Nuffield Department of Medicine as part of their series of video interviews. Hear more about how Dr. Palles uses whole genome sequencing with the aim of discovering genetic variants that affect susceptibility to colorectal cancer and Barrett’s oesophagus.